Published in

Public Library of Science, PLoS ONE, 6(9), p. e96849, 2014

DOI: 10.1371/journal.pone.0096849

Links

Tools

Export citation

Search in Google Scholar

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

Journal article published in 2014 by Moniek M. Vedder, Mirari Márquez, Esther W. de Bekker-Grob, Malu L. Calle, Lars Dyrskjøt, Manoils Kogevinas, Ulrika Segersten, Per-Uno Malmström, Ferran Algaba, Torben F. Ørntoft, Willemien Beukers, Torben F. Orntoft, Ellen Zwarthoff, Francisco X. Real ORCID, Nuria Malats and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Objective: We aimed to determine the validity of two risk scores for patients with non-muscle invasive bladder cancer in different European settings, in patients with primary tumours. Methods: We included 1,892 patients with primary stage Ta or T1 non-muscle invasive bladder cancer who underwent a transurethral resection in Spain (n = 973), the Netherlands (n = 639), or Denmark (n = 280). We evaluated recurrence-free survival and progression-free survival according to the European Organisation for Research and Treatment of Cancer (EORTC) and the Spanish Urological Club for Oncological Treatment (CUETO) risk scores for each patient and used the concordance index (c-index) to indicate discriminative ability. Results: The 3 cohorts were comparable according to age and sex, but patients from Denmark had a larger proportion of patients with the high stage and grade at diagnosis (p